|
Market Closed -
NYSE
16:00:02 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 329.93 USD | +1.91% |
|
+1.50% | +31.51% |
| 10:08am | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 10-21 | Labcorp Holdings Inc. Quarterly Dividend, Payable on December 11, 2026 | CI |
Company Valuation: Labcorp Holdings Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30,070 | 20,864 | 19,297 | 19,180 | 20,798 | 26,256 | - | - |
| Change | - | -30.62% | -7.51% | -0.61% | 8.43% | 26.24% | - | - |
| Enterprise Value (EV) 1 | 34,110 | 25,774 | 23,815 | 23,993 | 25,850 | 31,407 | 30,765 | 30,081 |
| Change | - | -24.44% | -7.6% | 0.75% | 7.74% | 21.49% | -2.04% | -2.22% |
| P/E | 12.9x | 16.9x | 47.6x | 25.9x | 24x | 23.2x | 20.9x | 18.8x |
| PBR | 2.85x | 2.06x | 2.42x | 2.38x | 2.39x | 2.92x | 2.61x | 2.32x |
| PEG | - | -0.4x | -0.7x | 0.3x | 1.3x | 0.7x | 1.9x | 1.7x |
| Capitalization / Revenue | 1.87x | 1.4x | 1.59x | 1.47x | 1.49x | 1.78x | 1.7x | 1.62x |
| EV / Revenue | 2.12x | 1.73x | 1.96x | 1.84x | 1.85x | 2.13x | 1.99x | 1.86x |
| EV / EBITDA | 8.11x | 8.82x | 11.5x | 11x | 10.8x | 12.2x | 11.3x | 10.5x |
| EV / EBIT | 8.9x | 10.1x | 13.9x | 13.4x | 12.9x | 14.4x | 13.3x | 12.2x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | 2.88 | 2.88 | 2.88 | 2.914 | 2.946 | 3.01 |
| Rate of return | - | - | 1.27% | 1.26% | 1.15% | 0.9% | 0.91% | 0.93% |
| EPS 2 | 24.39 | 13.97 | 4.77 | 8.84 | 10.46 | 13.93 | 15.46 | 17.19 |
| Distribution rate | - | - | 60.4% | 32.6% | 27.5% | 20.9% | 19% | 17.5% |
| Net sales 1 | 16,121 | 14,877 | 12,162 | 13,009 | 13,952 | 14,749 | 15,465 | 16,216 |
| EBITDA 1 | 4,207 | 2,924 | 2,072 | 2,184 | 2,403 | 2,574 | 2,723 | 2,858 |
| EBIT 1 | 3,831 | 2,549 | 1,715 | 1,797 | 2,002 | 2,182 | 2,318 | 2,457 |
| Net income 1 | 2,377 | 1,279 | 418 | 746 | 876.5 | 1,130 | 1,242 | 1,319 |
| Net Debt 1 | 4,040 | 4,910 | 4,518 | 4,813 | 5,052 | 5,151 | 4,509 | 3,825 |
| Reference price 2 | 314.21 | 235.48 | 227.29 | 229.32 | 250.88 | 323.75 | 323.75 | 323.75 |
| Nbr of stocks (in thousands) | 95,700 | 88,600 | 84,900 | 83,639 | 82,900 | 81,100 | - | - |
| Announcement Date | 2/10/22 | 2/16/23 | 2/15/24 | 2/6/25 | 2/17/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 23.24x | 2.13x | 12.2x | 0.9% | 26.26B | |
| 13.6x | 0.41x | 8.58x | 2.85% | 120B | |
| 15.49x | 1.9x | 9.5x | 0.68% | 99.46B | |
| -289.6x | 20.1x | -339.84x | -.--% | 59.59B | |
| 13.63x | 1.52x | 9.16x | 2.56% | 28.82B | |
| 23.49x | 2.62x | 13.29x | 1.38% | 26.37B | |
| 8.17x | 1.46x | 6.62x | -.--% | 21.67B | |
| 29.43x | 5.37x | 22.29x | 2.37% | 20.08B | |
| 20.22x | 1.81x | 9.1x | 3.51% | 18.97B | |
| 31.04x | 2.89x | 13.03x | 1.45% | 17.19B | |
| Average | -11.13x | 4.02x | -23.61x | 1.57% | 43.79B | |
| Weighted average by Cap. | -24.62x | 4.17x | -37.35x | 1.55% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- LH Stock
- Valuation Labcorp Holdings Inc.
Select your edition
All financial news and data tailored to specific country editions
